share_log

We Ran A Stock Scan For Earnings Growth And Intuitive Surgical (NASDAQ:ISRG) Passed With Ease

We Ran A Stock Scan For Earnings Growth And Intuitive Surgical (NASDAQ:ISRG) Passed With Ease

我们对盈利增长进行了股票扫描,而直觉外科公司(纳斯达克:ISRG)轻松通过了检查
Simply Wall St ·  10/03 06:03

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even companies that have no revenue, no profit, and a record of falling short, can manage to find investors. But the reality is that when a company loses money each year, for long enough, its investors will usually take their share of those losses. A loss-making company is yet to prove itself with profit, and eventually the inflow of external capital may dry up.

对于一些投机者来说,投资一家能扭转乾坤的公司的激动人心的是一个很大的吸引力,所以即使是没有营业收入、没有盈利,并且营业额不达标的公司也可以找到投资人。但现实情况是,当一家公司亏损多年后,其投资者通常会分担其中的损失。一家亏损的公司尚未证明其能带来利润,并且外部资本的流入最终可能会枯竭。

So if this idea of high risk and high reward doesn't suit, you might be more interested in profitable, growing companies, like Intuitive Surgical (NASDAQ:ISRG). While profit isn't the sole metric that should be considered when investing, it's worth recognising businesses that can consistently produce it.

因此,如果这种高风险高回报的想法不适合您,您可能更感兴趣的是像直觉外科公司(纳斯达克:ISRG)这样盈利增长的公司。尽管利润不是投资时唯一应考虑的指标,但值得注意的是一些能够持续产生利润的企业。

Intuitive Surgical's Earnings Per Share Are Growing

直觉外科公司的每股收益正在增长

If you believe that markets are even vaguely efficient, then over the long term you'd expect a company's share price to follow its earnings per share (EPS) outcomes. That makes EPS growth an attractive quality for any company. We can see that in the last three years Intuitive Surgical grew its EPS by 8.7% per year. That growth rate is fairly good, assuming the company can keep it up.

如果您相信市场甚至稍微有效,那么从长期来看,您预计公司的股价会遵循其每股收益(EPS)的结果。这使得EPS增长对于任何公司都是一种吸引人的品质。我们可以看到,在过去三年中,直觉外科公司的每股收益平均每年增长8.7%。假设公司能够保持这种增长速度,那将是相当不错的。

One way to double-check a company's growth is to look at how its revenue, and earnings before interest and tax (EBIT) margins are changing. While we note Intuitive Surgical achieved similar EBIT margins to last year, revenue grew by a solid 14% to US$7.6b. That's a real positive.

检查公司增长的一种方法是查看其营业收入和利息税前利润(EBIT)利润率的变化。尽管我们注意到直觉外科公司的EBIT利润率与去年相似,但营业收入增长了14%,达到76亿美元。这是一个真正的积极因素。

In the chart below, you can see how the company has grown earnings and revenue, over time. For finer detail, click on the image.

在下面的图表中,您可以看到公司的盈利和收入随着时间的推移而增长。要获得更精细的详细信息,请单击图像。

big
NasdaqGS:ISRG Earnings and Revenue History October 3rd 2024
纳斯达克纳斯达克股票代码:ISRG 直觉外科公司盈利和营业收入历史数据2024年10月3日

Of course the knack is to find stocks that have their best days in the future, not in the past. You could base your opinion on past performance, of course, but you may also want to check this interactive graph of professional analyst EPS forecasts for Intuitive Surgical.

当然,诀窍在于找到那些未来业绩辉煌的股票,而不是过去的。你可以基于过去的表现来形成观点,但你也可能想要查看这个专业分析师EPS预测的互动图表。

Are Intuitive Surgical Insiders Aligned With All Shareholders?

直觉外科公司内部人士是否与所有股东保持一致?

We would not expect to see insiders owning a large percentage of a US$172b company like Intuitive Surgical. But we do take comfort from the fact that they are investors in the company. We note that their impressive stake in the company is worth US$849m. While that is a lot of skin in the game, we note this holding only totals to 0.5% of the business, which is a result of the company being so large. This should still be a great incentive for management to maximise shareholder value.

我们不会期望看到内部人士拥有像直觉外科公司这样的一家价值为1720亿美元的公司的大部分股份。但我们对他们是公司投资者的事实感到安慰。我们注意到他们在公司的令人印象深刻的股权价值为84900万美元。虽然这是巨额投资,但我们注意到这一持股仅占业务的0.5%,这是因为公司规模如此之大。这仍然应该是管理层最大限度地提高股东价值的动力。

Does Intuitive Surgical Deserve A Spot On Your Watchlist?

直觉外科公司是否值得加入你的自选股列表?

One positive for Intuitive Surgical is that it is growing EPS. That's nice to see. If that's not enough on its own, there is also the rather notable levels of insider ownership. The combination definitely favoured by investors so consider keeping the company on a watchlist. Still, you should learn about the 1 warning sign we've spotted with Intuitive Surgical.

对直觉外科公司的一个积极因素是其不断增长的每股收益。这是一个好迹象。如果这本身还不够的话,还有相当显著的内部持股水平。这种组合绝对受到投资者青睐,因此考虑将公司保留在自选股列表中。不过,你应该了解我们发现的直觉外科公司的1个警示信号。

There's always the possibility of doing well buying stocks that are not growing earnings and do not have insiders buying shares. But for those who consider these important metrics, we encourage you to check out companies that do have those features. You can access a tailored list of companies which have demonstrated growth backed by significant insider holdings.

总是有可能买入未增长收益并且内部人员不买入股票的股票表现良好。但是对于那些认为这些重要指数的人,我们鼓励您查看具有这些功能的公司。您可以访问定制列表,其中列出了已经展示出增长并得到内幕人员认可的公司。

Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction.

请注意,本文讨论的内部交易是指在相关司法管辖区中报告的交易。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发